Documents
Application Sponsors
Marketing Status
Application Products
001 | INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL | 800MG/50ML | 2 | PORTRAZZA | NECITUMUMAB |
FDA Submissions
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 2015-11-24 | STANDARD |
Submissions Property Types
CDER Filings
ELI LILLY CO
cder:Array
(
[0] => Array
(
[ApplNo] => 125547
[companyName] => ELI LILLY CO
[docInserts] => ["",""]
[products] => [{"drugName":"PORTRAZZA","activeIngredients":"NECITUMUMAB","strength":"800MG\/50ML","dosageForm":"INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL","marketingStatus":"Prescription","te":"None","rld":"TBD","rs":"No"}]
[labels] => [{"actionDate":"11\/24\/2015","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/125547s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"11\/24\/2015","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"N\/A","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/125547s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2015\\\/125547Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2015\\\/125547Orig1s000TOC.cfm\"},{\"name\":\"Summary Review (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2015\\\/125547Orig1s000SumR.pdf\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2015-11-24
)
)